CXCR4-Directed PET/CT with [68Ga]Pentixafor in Central Nervous System Lymphoma: A Comparison with [18F]FDG PET/CT
ConclusionsCXCR4-directed PET/CT using [68 Ga]Pentixafor, with excellent tumor-to-background contrast, might be a more promising agent for the detection of lesions in CNSL patients than [18F]FDG PET/CT.
Source: Molecular Imaging and Biology - Category: Molecular Biology Source Type: research
More News: Biology | Brain | Brain Cancers | Chemotherapy | CT Scan | Lymphoma | Molecular Biology | MRI Scan | Neurology | PET Scan | Study